NCT07381985
Strategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesUniversity of Vermont Medical CenterInvestigator-initiated
~200 participants
Updated 2026-02-02 on ClinicalTrials.gov
What's tested:Longitudinal Cancer Genetics Follow-Up Program
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence to Cancer Prevention and Surveillance Guidelines
Measured over Baseline, 12 months, and 24 months
Conditions
Where it's being run
1 sites across 1 statesVermont1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients of all genders must be ≥ 18 years of age.
Patients must have a known pathogenic germline variant in a cancer risk gene that was identified by a CLIA-approved lab more than one year ago.
Patients must be able to accurately provide self-report data (i.e., per clinical judgment, cognitive function is intact).
Patients must be able to complete questionnaires in English.
Patients must have the ability to provide informed consent.
What this trial measures
- Adherence to Cancer Prevention and Surveillance GuidelinesBaseline, 12 months, and 24 months
Proportion of participants who are adherent to National Comprehensive Cancer Network (NCCN) guideline-recommended cancer risk-reducing strategies-including surveillance imaging, colonoscopy, chemoprevention, and prophylactic surgeries-measured at baseline, 12 months, and 24 months. Adherence will be determined through a gene-specific adherence survey completed during clinic visits and supported by clinical documentation.